Related Experiment Video
Updated: Dec 29, 2025

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation
Stefanie Voigt1, Kai R Sterz1, Fabian Giehler1,2
1Helmholtz Centre Munich - German Research Centre for Environmental Health, Research Unit Gene Vectors, Marchioninistrasse 25, 81377, Munich, Germany.
Abstract:
IκB kinase 2 (IKK2) is well known for its pivotal role as a mediator of the canonical NF-κB pathway, which has important functions in inflammation and immunity, but also in cancer. Here we identify a novel and critical function of IKK2 and its co-factor NEMO in the activation of oncogenic c-Jun N-terminal kinase (JNK) signaling, induced by the latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV). Independent of its kinase activity, the TGFβ-activated kinase 1 (TAK1) mediates LMP1 signaling complex formation, NEMO ubiquitination and subsequent IKK2 activation. The tumor progression locus 2 (TPL2) kinase is induced by LMP1 via IKK2 and transmits JNK activation signals downstream of IKK2. The IKK2-TPL2-JNK axis is specific for LMP1 and differs from TNFα, Interleukin-1 and CD40 signaling. This pathway mediates essential LMP1 survival signals in EBV-transformed human B cells and post-transplant lymphoma, and thus qualifies as a target for treatment of EBV-induced cancer.
Insights
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) activates oncogenic c-Jun N-terminal kinase (JNK) signaling through IκB kinase 2 (IKK2) and TPL2 kinase. This novel IKK2-TPL2-JNK pathway promotes survival in EBV-driven cancers, offering a potential therapeutic target.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- IκB kinase 2 (IKK2) is a key regulator of the NF-κB pathway involved in inflammation, immunity, and cancer.
- Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) is an oncogenic protein implicated in various cancers.
Purpose of the Study:
- To elucidate the novel role of IKK2 and NEMO in LMP1-induced oncogenic signaling.
- To identify the specific signaling axis responsible for LMP1-mediated cell survival in EBV-associated malignancies.
Main Methods:
- Investigated the interaction between LMP1, TAK1, NEMO, IKK2, and TPL2.
- Analyzed the activation of c-Jun N-terminal kinase (JNK) signaling downstream of IKK2.
- Examined the role of the IKK2-TPL2-JNK pathway in EBV-transformed B cells and post-transplant lymphoma.
Main Results:
- Identified a novel function of IKK2 and NEMO in activating LMP1-induced JNK signaling, independent of canonical NF-κB.
- Demonstrated that TGFβ-activated kinase 1 (TAK1) mediates LMP1 signaling complex formation and IKK2 activation.
- Showed that TPL2 kinase is induced by LMP1 via IKK2 and transmits JNK activation signals.
- Established that the IKK2-TPL2-JNK axis is specific to LMP1 signaling and distinct from other inflammatory pathways.
- Confirmed that this pathway mediates essential survival signals for LMP1 in EBV-transformed cells and lymphomas.
Conclusions:
- The IKK2-TPL2-JNK signaling axis is a critical, LMP1-specific pathway mediating cell survival in EBV-induced cancers.
- Targeting this pathway presents a promising therapeutic strategy for treating EBV-associated malignancies like post-transplant lymphoma.
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
MAPK Signaling Cascades
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

